Metabolism, 53 , 1002-1006
Monitor blood sugar levels in diabetic patients Regularly assess kidney function during treatment Ensure gradual dose escalation to reduce GI side effects Not recommended during pregnancy or breastfeeding Contraindications: Personal or family history of medullary thyroid carcinoma Multiple endocrine neoplasia syndrome type 2 (MEN 2) Known hypersensitivity to semaglutide or any component Severe gastrointestinal disease (e.g., gastroparesis) Pregnancy Interactions: May delay absorption of oral medications Use with insulin or other GLP-1 agonists can increase risk of hypoglycemia Interaction with sulfonylureas may require dose adjustments Reduced effectiveness of oral contraceptives due to delayed gastric emptying Caution with diuretics or medications that cause dehydration
Alcoholic beverages often contain a lot of histamine
We did not observe any change in spontaneous physical activity level and we found that calorie-matched group did not lose weight to the same extent as the Melanotan-treated animals, suggesting that the drug increases energy expenditure
Not only the environmental factors, but the biochemistry also supports their combination
GLP-1 and GLP-1RAs are known to be effective in many chronic diseases, including diabetes, due to their antioxidant mechanisms
